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Many chemicals which have been demon-
strated to be mutagenic in a variety of or-
ganisms are either present in our environ-
ment or are used-for human consumption.
A variety of techniques have been developed
for the detection of chemical mutagens. Some
of these techniques have recently been re-
viewed and compiled (1). The important
question, from the viewpoint of using these
testing systems as a guide to human re-
sponsiveness, is one concerning the relev-
ance of the results obtained from such tests
to the actual or potential mutagenic hazard
to man. We know too little to provide simple
answers to the question, but a screening
system utilizing the metabolism of potential
mutagens or carcinogens by intact animals
appears to be the most direct means of ob-
taining results that are as relevant as pos-
sible to man.
Fischer first developed a cell culture sys-
tem for detection of mutagens using mouse
leukemic L5178Y cells; this system was
later combined with the metabolic capabil-
ity of the animal host in the development
of a host-mediated assay system in 1969 (2).
This system seems to be very useful for de-
tecting potential mutagens in man since it
detects mutagenic effects of compounds in
mammalian cells. These compounds are
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either directly mutagenic or not mutagenic
themselves but are metabolized by the animal
or man to form a mutagen. Although the
basic genetic material is the same in all
organisms and mutations are caused by
the same types of DNA alteration, the
mechanisms by which these alterations are
induced and factors, such as repair system,
transport across cellular membrances, struc-
ture of chromosomes, and metabolic activity,
by which the processes are influenced, could
be different in different organisms. Since
we know very little about these mechanisms
especially in higher organisms, results from
mutagenesis systems employing a mammalian
cell as the target cell may prove valuable in
relating chemical mutagenicity data to hu-
man health hazards. We know that respon-
siveness of a compound to mutagenesis often
varies greatly from one testing system to
another.
One of the limitations of a host-mediated
assay system is that the level of test com-
pound must be nonlethal to the animal. It is
established that most mutagens, including ra-
diation, are highly effective only at concen-
trations that are lethal. This limitation, how-
ever, could be a pharmacological advantage
because it reflects conditions of human
exposure. It should be remembered that the
question we are asking is not whether the
compound might have mutagenic activity in
some organism when exposed at any dosage,
..December 1973 145but whether the physiological doses of the
compound in man are accompanied by any
significant mutagenic or carcinogenic risk.
The mutagenic action of the substance at a
toxic level can be determined by in vitro as-
say with the same cell line. The compari-
son of this result with that of the host-
mediated assay can then provide a clear un-
derstanding of the effect of host metabolism.
L5178Y is a fairly stable mammalian cell
line with a near-diploid karyotype. These
cells grow in suspension culture in large
numbers, allowing statistically meaningful
experiments. Sublines specially selected for
mutagenesis studies possess a high level of
infectivity in genetically compatible mice
(BDF, DBA, AKR, etc.). Cells grow in vivo
exponentially up to approximately 1 x 108
cells/ml in peritoneal fluid with a doubling
time of approximately 14 hr. Cells obtained
directly from the host are capable of re-
producing with high cloning efficiency. The
assay system was developed to detect the in-
duction of forward point mutations as op-
posed to back mutations. The forward muta-
tion system permits the detection of muta-
tions at many genetic loci simultaneously,
whereas the back mutation system usually
permits the detection of mutations at only one
genetic locus. In forward mutagenesis, the in-
duced mutants can be of many different types
revealing various point mutations. The back-
mutation system is designed to detect a
specific type of mutation (3). This combined
with the well known fact that mutagenic
specificity exists indicates that the forward
mutation assay seems to be more suited as
an initial screening test for potential muta-
gens. Various genetic markers are avail-
able for simultaneouo detection of mutations
at many different genetic loci in L5178Y
cells and the biochemical consequences of
the mutations have been e licidated in pre-
vious works (4-6).
Before any particular test system is used
in the screening of a large number of
chemicals for mutagenicity, it is important
to determine whether the test system will
in fact be effective in detecting a variety of
known mutagens. The results would not only
characterize the testing system for its sen-
sitivity and specificity toward the various
types of mutagens but also establish the
optimum conditions and limitations of mut-
agenicity testing. As a part of our study on
cancer therapeutic agents, we have ex-
amined a number of these agents for their
mutagenic activity using the host-mediated
assay system. Some of the results obtained
in response to these drugs and certain
known mutagens are presented here, and
some of the problems connected with muta-
genicity testing are also discussed.
In this study, we have chosen markers
which confer resistance to three selective
agents (thymidine, cytosine arabinoside, and
methotrexate). Many different mutants with
varying degrees of resistance comprise each
type of mutant. Therefore, the mutant fre-
quency (MF) changes with levels of selec-
tive! agents employed. AKD2F1 hybrid mice
weighing about 20 g each are used for this
assay. In all the experiments presented here
mic,e were inoculated intraperitoneally with
106f cells. Three days later drugs under inves-
tigation were administered by subcutaneous
injection. Although a single dose was given
by subcutaneous route in experiments dis-
cussed here, one advantage of this system
is that by using lower inoculum of target cell
it is possible to administer test substances
daily by various routes for as long as two
weeks. The drug dosages employed in this
study were all nontoxic to the target cells
in order to exclude the possibility of selec-
tion in favor of mutants. Three days after
drug treatment the cells were recovered and
mutLant frequencies were determined using
the soft-agar cloning method (7). Total cell
nunriber from each mouse was always deter-
mined in order to insure that the drug doses
used were not toxic to the target cells. Op-
timum expression time for maximum mu-
tant; recovery was 2-3 days. Figures 1 and 2
and Tables 1-3 show examples of positive
mutagenic response obtained from this
study. Ethyl methanesulfonate (EMS) and
5-bromodeoxyuridine (BUdR) were used as
positive controls. Because of low sensitivity,
experiments frequently had to be repeated
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FIGURE 1. Induction of MTX-resistant mutants by
EMS in the host-mediated assay. Each mouse was
injected intraperitoneally with 101 cells. Three days
after the inoculation, mice were injected sub-
cutaneously with a single dose of EMS as indi-
cated. Three days after the administration of
EMS, cells were recovered from ascitic fluid and
mutants were determined by the soft-agar cloning
method using MTX as the selective agent. Num-
bers in parentheses indicate number of mutants
recovered.
The standard error of the mean was calculated by
using 15 samples from four experiments.
many times in order to obtain statistically
meaningful results. Nevertheless, it was clear
that this system responded well to some of
the known mutagens. This system seems to
respond to various alkylating agents (Figs.
1 and 2; Tables 2 and 3). Here the effect of
host metabolism can also be seen. Both cyto-
xan and triethylene thiophosphoramide (thio
TEPA) which gave positive response in this
assay are known to require metabolic activa-
tion. Cytoxan was negative in our in vitro
assay. It is interesting to note the high
magnitude of response to BUdR and IUdR
(Table 1). FUdR and a few other nucleo-
side analogs we tested were negative in this
((7
0
10 C
E
0 200 400
EMS mg/kg mice
FIGURE 2. Induction of dTR-resistant mutants by
EMS in the host-mediated assay. The assay pro-
cedure was exactly the same as that of Fig. 1,
except dTR was used as the selective agent.
system. This system responded to at least one
frameshift mutagen, hyeanthone (Table 2)
(8). We do not as yet know if this system
responds only to certain types of frame-
shift mutagens. Proflavin, quinacrine, and
ethidium bromide gave negative responses.
Before any significance concerning muta-
genicity of a compound is discussed, especi-
ally of those which showed negative re-
sponses, it must be considered that all experi-
Table 1. Induction of MTX-Resistant Mutants by
BUdR and IUdR in the host-mediated assay.
Dose,
mg/kg MF x 106 a
BUdR 0 7.25 ± 2.0(4)
150 81.5 t 4.0(4)
500 152.5 ± 30.2(4)
IUdR 0 9.25 ± 0.6(5)
500 201 ± 25.0(5)
*Values
minations.
in parentheses indicate number of deter-
December 1973 147Table 2. Induction of mutation by TEM, thio-TEPA,
and hycanthone.
MF x 1' a
Dose, mg/kg MTX dTR
TEM 0 4.67 ± 1.27(7) 7.82 ± 2.87(4)
0.5 22.9 ± 5.3(8) 34.0 ± 8.45(4)
Thio-TEPA 0 4.65 ± 1.12(9) 1.15 ± 0;32(9)
7.5 20.9 ± 4.62(7) 50.25 ± 19.6(7)
Hyeanthone 0 13.7 5A 2.1(4) 5.4 ± 2.22(4)
100 36.2 ± 4.32(4) 19.4- 9.15(4)
a Values in parentheses indicate number of determinations. - -
Table 3. Induction of mutation by cyclophosphamide etists'at the conditions of the standard assay
in the host-mediated assay. and, to further determine whether a testing
compound has a- selective lethal effect on MF X 106^ amutants or sensitive cells. Our system is
Selective
agent
MTX
dTR
Ara-C
' Values
minations.
Control
7.5 ± 1.4(16)
14.3 ± 2.9(16)
1.83 ± 0.67(15)
Cytoxan
(100 mg/kg)
30.2 ± 4.2(8)
68.4 ± 13.2(8)
5.35 ± 1.6(7)
in parentheses indicate number of deter-
ments were carried out with acute, subtoxic
administration of drugs. Another important
consideration is the possibility that the in-
crease in mutants represents selection by the
test compounds. If the compounds were not
inducing mutations but acting as selective
agents then a -large proportion of mutants
would be recovered in the final population
of treated cell samples. The fact that no
toxicity to target cells was detected with the
doses of drugs used in the assay (almost
the same number of cells were harvested
from the control and treated mice) suggests
that there was no selection against the sen-
sitive cells by the drugs. However, the pos-
sibility that mutants were selected against
is not excluded, in which case the actual
number of mutants induced would have been
higher than that recovered, and the mutant
frequencies given would have been under-
estimated. Reconstruction experiments
must resolve this question, their purpose
being to determine whether a selective ad-
vantage for mutants or the sensitive cell
a forward mutagenesis in which many dif-
ferent' typ'es 'of mutants arise from muta-
tions at more than one genetic locus. There-
f-ore reconstruction experiments are very
difficult to carry out. This may be one of
the intrinsic disadvantages of a forward
mutagenesis system. We have examined
many mutants, either induced or derived
spontaneously. A number of reconstruction
experiments were performed using either
isolated mutants or "representative" mutants
which were a mixture of mutants recovered
from any particular experiment. One such
experiment is shown in Table 4. Results ob-
tained from all the reconstruction experi-
ments were entirely consistent with our pre-
vious interpretation that the increased
number of mutants in the treated samples
was induced by the mutagen. However, as
seen in Table 4, for all the mutants tested
there was an appreciable selection against
mutants by the host animal, although their
degree of selection was variable. This ob-
servation is somewhat surprising, because
the in vivo growth rate of the mutants was
similar to that of the sensitive cells when
tested separately. One possible explanation
is that sensitive cells affect the reproduction
of mutant cells in culture and in mice. Al-
though this host selective force hinders the
quantitative measurement of mutagenesis in
the host-mediated system, this-is still-e use-
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numbers of potential mutagens and carcino-
gens. Positive controls such as EMS and
BUdR have been used to estimate relative
intensity of mutagenic compounds.
A great deal of additional information has
been obtained from our mutant studies which
was helpful to validate some important as-
sumptions made for the host-mediated mut-
agenesis test system. This information in-
cludes: (1) the reproduction of mutant lines
in the peritoneal cavity of mice has been
found to be reproduceable and similar to
the parent line; (2) various mutants ob-
tained directly from the host grow in culture
at a similar rate to sensitive cells (some mu-
tants, however, grow a little slowly in the
presence of the corresponding selective
agents); (3) cloning efficiencies of mutants
in the soft-agar method are similar to sen-
sitive cells; and (4) recovery of mutants by
the soft-agar method is unaffected by the
presence of sensitive cells.
The most important assumption made in
our system is that the phenotypic change
to resistancy is caused by gene mutation.
There are views which contradict this as-
sumption (9). However, many biochemical
studies of L5178Y mutants and other so-
matic mammalian culture cells, and studies
of hybrid strains produced by fusing cells
together with drug resistance are consis-
tent with the interpretation that the pheno-
typic shifts are of genetic origin.
Table 4. Reconstruction of experiment with a
MTX-resistant mutant (Ml) in the host-
mediated assay.
Inoculated Recovered
No. of No. of
cells MF Treatment cells MF
Ml 106 1 None 2.8 x 1G8 1.0
1% Ml 10 1 x 1O-2 None 2.5 x 108 0.12 x 10-2
1% Ml 106 1 X 10-2 EMS (250 mg/kg) 2.3 x 10 0.18 X 10-2
1% Ml 106 1 X 10-2 IUdR (500mg/kg) 2.6 x 108 0.10 X 10-2
One area for future improvement in the
host-mediated L5178Y cell system would be
the isolation of more sensitive sublines to
mutagens, preferably repair enzyme-deficient
mutants. This would not only improve sen-
sitivity of the assay system, but would also
provide valuable information on repair sys-
tems in mammalian cells. We are making an
effort in this direction.
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